Current status: 956 hESC lines, 5283 hiPSC lines, and 128 clinical studies, and 1891 certificates
Monthly statistic from Dec 1, 2023
Posted on December 1, 2023
| total lines | 6239 |
| hESC lines | 956 |
| hiPSC lines | 5283 |
| derivation countries | 46 |
| projects | 282 |
| providers | 866 |
| clinical studies | 128 |
| subclones | 2447 |
| certificates | 1891 |
| cell line certificates | 1747 |
| project certificates | 144 |